@BettyKimLab
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own
Houston, TX
Joined February 2016
- Tweets1.1K
- Following762
- Followers1.9K
- Likes3.4K
Highlight of my career.
James Allison @NobelPrize Medicine 2018,
Phil Sharp @NobelPrize Medicine 1983,
Carolyn Bertozzi @NobelPrize Chemistry 2022, @PamSharmaMDPhD #Mentor. #Inspiring. @MDAndersonNews #oncsurgery
Honored to present @MDAndersonNews James Allison Institute with 5 @NobelPrize (James Allison, Carolyn Bertozzi, Fred Ramsdell, Gary Ruvkun, Phil Sharp) with all-stars Antoni Ribas, Elaine Mardis, Nina Bhardwaj, Cathy Wu, Andrea Shietinger, Marcia Haigis, Wen Jiang, Pam Sharma.
First month of kindergarten
I cannot believe they were the size of @MiffyOfficialUS
#blessed
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research.
We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll
#EndCancer
ALT Graphic congratulating 2025 Sabin Family Fellows, including: Ruoyan Li , Ph.D. Emil Schueler , Ph.D. Hind Rafei , M.D. Ghayas Issa, M.D. Osama Mohamad, M.D., Ph.D. Guillermo Montalban Bravo, M.D. Andrew Dunbar, M.D. Emily Keung, MD, AM, FACS. Jason M. Schenkel , M.D., Ph.D. Mackenzie Wehner , M.D.
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
I’ve Joined @MDAndersonNews as an Assistant Professor and Physician-Scientist in Radiation Oncology - @BenjaminSchrank
@BettyKimLab @ACKoongMDPhD
oncodaily.com/blog/benjamin-…
#RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc
Happy Father’s Day to the #BestDad in the world.
Excited to moderate #GRC First Day Gordon Research Conference and our Airport Shuttle bus experienced slight technical issues…2 hours later almost had to hitchhike our way to #Tuscany. Looking forward to what this week will bring. #CancerNanomedicine
As we graduate our extraordinary fellows and residents, I am reminded of how little I knew when I thought I knew. From Highschool to Fellowship-Trained Neurosurgeon Scientist: 26 years.Thank you Mom, Dad, Wen, Hannah, teachers/mentors and our patients.
Thanks so much Kate for sharing all of your dolls with us! The collection is now complete with #Ariel and #Rapunzel @American_Girl @Disney
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound
@lux_jacques @BettyKimLab
@YWangPhD @UAZNeurosurgery
advanced.onlinelibrary.wiley… – at Tucson, AZ
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
Why do tumors evade immune detection, even when phagocytosed? - @BenjaminSchrank
@BettyKimLab @MDAndersonNews @YWangPhD @DYLee_BME @AnnetteWu9
oncodaily.com/blog/benjamin-…
#Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate
@MDAndersonNews @BenjaminSchrank @BettyKimLab
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. 🧬
According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies💊
oncodaily.com/science/the-un…
#Cancer #CancerResearch #CancerTreatment #MedEd #MedNews #MedX #Medicine #Health #Oncology #OncoDaily
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing such valuable content.
oncodaily.com/blog/benjamin-…
Buckeroo breakfast with Daddy today. #NowWeAre5
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
MD Anderson researchers have developed a novel antibody toxin-conjugate that’s not designed to kill the cancer cells directly.
Read how this new approach is designed to trigger the body's natural immune response instead: brnw.ch/21wQWWK #EndCancer
Thank you @ASCO for featuring our study: Novel Antibody-Toxin Conjugate Evaluated in Early Study
Stay tuned as we work towards bringing this to our patients @MDAndersonNews
@BenjaminSchrank
@YWangPhD ascopost.com/news/february-2…
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE retweeted
Congrats @BenjaminSchrank on this study showing proof of concept that an antibody-toxin conjugate can be used to facilitate immune recognition of tumors. Very promising approach for the development of new cancer therapies! #endcancer @MDAndersonNews
nature.com/articles/s43018-0…
